From April 22, 2022 to June 30, 2022, the company has repurchased 256,700 shares, representing 0.15% for CNY 4.86 million. With this, the company has completed the repurchase of 256,700 shares, representing 0.15% for CNY 4.86 million under the buyback announced on April 22, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.21 CNY | -5.99% | -15.83% | -29.39% |
23/05 | Hvsen Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024 | CI |
25/04 | Hvsen Biotechnology Co., Ltd. Proposes Final Cash Dividend for 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-29.39% | 23Cr | |
+22.62% | 902.87Cr | |
+24.38% | 368.33Cr | |
+2.09% | 339.25Cr | |
+15.54% | 167.43Cr | |
-1.17% | 128.5Cr | |
-26.28% | 122.42Cr | |
-30.27% | 116.56Cr | |
-21.20% | 103.01Cr | |
-11.84% | 92Cr |
- Stock Market
- Equities
- 300871 Stock
- News Hvsen Biotechnology Co., Ltd.
- Tranche Update on Hvsen Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 22, 2022.